Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy

By Ben-Ari Z.   Mor E.   Shaharabani E.   Bar-Nathan N.   Shapira Z.   Tur-Kaspa R.  

Transplantation Proceedings, Vol. 32, Iss. 4, 2000-06 ,pp. : 709-710

Elsevier

Access to resources Recommend Favorite

Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients

By Boucher A.   Masse M.   Lauzon L.   Morin M.   Dandavino R.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1799-1802

Elsevier

Access to resources Recommend Favorite

Individualization of maintenance immunosuppressive therapy equalizes acute rejection risk in African American versus non-African American renal allograft recipients

By Lewis R.   Coutee J.   Kostro B.   Calvert D.   Cava-Bartsch C.   Susskind B.   Swies G.   Burns T.  

Transplantation Proceedings, Vol. 33, Iss. 6, 2001-09 ,pp. : 2977-2979

Elsevier

Access to resources Recommend Favorite

Risk factors in renal transplantation and implications for immunosuppressive therapy

By Halloran P.F.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 351-352

Elsevier

Access to resources Recommend Favorite

Risk factors for noncompliance to immunosuppressive medications in renal transplant recipients

By Ghods A.J.   Nasrollahzadeh D.   Argani H.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2609-2611

Elsevier

Access to resources Recommend Favorite